ALLR

1.42

0.70% -0.01

Dopo l'orario di chiusura: 1.44 0.02 +1.41%

Allarity Therapeutics Inc (ALLR)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.43

Aprire:

$1.41

Volume 24 ore:

111.24K

Relative Volume:

0.79

Capitalizzazione di mercato:

$22.59M

Reddito:

$345.00K

Utile/perdita netta:

$-11.25M

Rapporto P/E:

-1.9676

EPS:

-0.7217

Flusso di cassa netto:

$-16.70M

1 W Prestazione:

+3.65%

1M Prestazione:

+16.39%

6M Prestazione:

+54.01%

1 anno Prestazione:

+61.55%

Intervallo 1D:

$1.38

$1.4919

Intervallo di 1 settimana:

$1.2522

$1.4919

Portata 52W:

$0.7687

$2.35

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Nome

Allarity Therapeutics Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

401-426-4664

Indirizzo

24 SCHOOL ST., 2ND FLOOR, BOSTON

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-21

Ultimi documenti SEC

ALLR's Discussions on Twitter

Compare ALLR vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ALLR Allarity Therapeutics Inc	1.42	22.75M	345.00K	-11.25M	-16.70M	-0.7217
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-28	Iniziato	Ascendiant Capital Markets	Buy

Allarity Therapeutics Inc Borsa (ALLR) Ultime notizie

Aug 19, 2026

Allarity (ALLR) Earnings Update: The Available Earnings Metric Delivers a Beat; Price Move: Shares Move 5.93% Higher for the Current SessionEarnings Seasonality - vinanet.vn

Aug 19, 2026

Aug 15, 2026

Allarity Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 15, 2026

Aug 14, 2026

Allarity Therapeutics Releases Q2 2026 Financial Results - AlphaStreet

Aug 14, 2026

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign - Investing News Network

Aug 14, 2026

Allarity Therapeutics Q2 EPS of $(0.21) beats $(0.25) estimate - scanx.trade

Aug 14, 2026

Allarity Therapeutics reports Q2 results, cash position - Investing.com

Aug 14, 2026

Allarity Therapeutics, Inc. 2026: Revenue $0 Net income ($3.41M), EPS ($0.21) — 10-Q Summary - TradingView

Aug 14, 2026

Allarity Therapeutics reports Q2 results, cash position By Investing.com - Investing.com Canada

Aug 14, 2026

Allarity Therapeutics (ALLR) adds $20M debt, holds $26.9M cash in Q2 2026 - Stock Titan

Aug 14, 2026

Allarity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready ... - Caledonian Record

Aug 14, 2026

Patent Gives Allarity’s Cancer-Drug Pairing Exclusivity Into 2042 - Stock Titan

Aug 14, 2026

ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView

Aug 14, 2026

Aug 13, 2026

Allarity Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Aug 13, 2026

Aug 11, 2026

ALLR Q1 2026 Earnings: Narrower-than-Expected Loss of -$0.17 Highlights Cost DisciplineEarnings Power Value - vinanet.vn

Aug 11, 2026

Aug 06, 2026

Allarity Therapeutics (ALLR) Edges Higher: Biotech Stock Tests Key $1.42 Resistance After +1.5% MoveCup and Handle - vinanet.vn

Aug 06, 2026

Aug 03, 2026

CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView

Aug 03, 2026

Allarity Therapeutics (ALLR) Gains 2.48% as Stock Holds Above Key Support ZoneDividend ETF - dars.gov.et

Aug 03, 2026

Jul 28, 2026